ISHRS 2023 CME Webinar January 25 – All You Want to Know About Female Hair Loss Restoration

ISHRS 2023 CME Webinar

All You Want to Know About Female Hair Loss Restoration

Presented on
Wednesday, January 25, 2023
Now Available on Demand
Duration: 2 hours

Available On Demand – Register below to view the recording

Registration Fees Per Webinar

  • Physician Attendee of ISHRS 2022 Panama World Congress, $0.00 USD
  • ISHRS Physician Member, Non-Attendee of ISHRS 2022 Panama World Congress, $75.00 USD
  • ISHRS Physician Pending-Member, Non-Attendee of ISHRS 2022 Panama World Congress, $100.00 USD
  • Physician Non-Member, Non-Attendee of ISHRS 2022 Panama World Congress, $125.00 USD
Register Here
PROGRAM OUTLINE (PDF)

Moderators

Robin Unger, MD | USA
Marie Schambach, MD, FISHRS | Guatemala

Program Description

The live online webinar will occur on the date and time as noted. The live program will be recorded and available for viewing on demand until Dec. 31, 2023. This 2-hour CME activity is a live webinar which will be recorded with the intention to be re-watched or viewed as on-demand education.

The program is intended for physicians who perform hair transplantation surgery utilizing either strip or FUE graft harvest methods. This webinar is being conducted to provide physicians knowledge on Female Hair Loss, from diagnosis all the way to medical, surgical and ancillary treatments. As a result of this activity, learners will be able to gain more knowledge to provide optimal results for patients. The online live component will include presentations, panel discussion, and audience participation via verbal questions and discussion and typed chat Q&A.

Professional Practice Gap

Female Hair Loss is more complex to diagnose and treat than men’s. There are pathologies specific to female patients, expectations and treatment risks specific for them. More frequently we are seeing female patients in our consultation and we should be prepared to address them correctly.

Educational Need

More than one third of women have clinically significant hair loss during their lifetime, and its effect on patients’ emotions is often greatly underestimated. Besides, due to the fast growing characteristic the hair follicle has, many metabolic derangements can be manifested with alopecia, and hair loss may be the first clinical sign of systemic disease. Diagnosis depends greatly on clinical examination, medical history, trichoscopy and confirmation by trichogram and biopsy if necessary. Treatment will vary greatly depending on diagnosis; from systemic medical treatment to surgical treatments, should be directed accordingly and expectations managed and explained.

A hair transplant surgeon needs to know the differences between pathologies and its medical and/or surgical treatment correlations, including ancillary treatments like mesotherapy, platelet rich plasma or scalp micropigmentation.

References

  1. Maja Kovacevic, Andy Goren, Jerry Shapiro, Rodney Sinclair, Neal M. Lonky, Mirna Situm, Vedrana Bulat, Zeljana Bolanca, John McCoy. (2017) Prevalence of hair shedding among women. Dermatologic Therapy 30:1, e12415. 
  2. Paulo Müller Ramos, Hélio Amante Miot. (2015) Female Pattern Hair Loss: a clinical and pathophysiological review. Anais Brasileiros de Dermatologia 90:4, 529-543. 
  3. Antonella Tosti, Bianca Maria Piraccini. 2014. Alopecia androgenetica femminile. Tricologia ambulatoriale, 53-65. 
  4. Saceda-Corralo, D., Moustafa, F., Moreno-Arrones, Ó., Jaén-Olasolo, P., Vañó-Galván, S., & Camacho, F. (2022). Mesotherapy with dutasteride for androgenetic alopecia: a retrospective study in real clinical practice. Journal of drugs in dermatology: JDD, 21(7), 742-747.
  5. Rassman, W. R., Pak, J. P., Kim, J., & Estrin, N. F. (2015). Scalp micropigmentation: a concealer for hair and scalp deformities. The Journal of Clinical and Aesthetic Dermatology, 8(3), 35.

Target Audience and Prerequisites

This webinar is taught at the physician level. It is open to all levels and geared toward advanced hair restoration surgeons.

Learning Objectives

As a result of participating in this activity, the learners should be able to:

  • Give proper diagnosis and recognize those pathologies which are not very common.
  • Describe the management of androgenetic alopecia and other types of alopecia common to women.
  • Discuss different surgical techniques and approaches specific to female hair loss.
  • Identify the specific moment to prescribe ancillary treatments in women – like scalp micropigmentation and/or mesotherapy.  

Continuing Medical Education (CME) Credit Statement

The International Society of Hair Restoration Surgery is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The International Society of Hair Restoration Surgery designates this Other Activity (blended synchronous and enduring) for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

To receive CME credit and a CME certificate, participants must participate in the activity, complete the evaluation survey and the CME Claim Form by Dec. 31, 2023.

Format

Internet/online, via computer or mobile device. 

Official Language

The official language of the webinar is English. Simultaneous interpretation is not provided for this webinar.

Disclosures of Relevant Financial Relationships of Planners, Faculty, and Others

The following individuals have no relevant financial relationships with ineligible companies to disclose:

Conradin von Albertini, MD, FISHRS – Planner
Waris Anwar, MBBS, FISHRS – Planner
Victoria Ceh, MPA – Planner & Manager
Bruno F. Ferreira, MD – Planner
Steven Gabel, MD, FISHRS – Planner
James A. Harris, MD, FISHRS – Planner
Rana Irfan, MBBS, FISHRS – Planner
Jenn Krejci, MD – Faculty
Nicole Large – Faculty
Emily Middag – Planner and Manager
Ratchathorn Panchaprateep, MD, PhD, FISHRS – Planner
Jae-Hyun Park, MD, PhD – Faculty
Marie A. Schambach, MD, FISHRS – Planner
Melanie Stancampiano – Planner & Manager
Alejandra Susacasa, MD – Faculty
Robin Unger, MD – Faculty
Mark A. Waldman, MD – Planner

The following individuals have relevant financial relationships:

None.

All of the relevant financial relationships listed for these individuals have been mitigated.

Commercial Support

None.

Off-Label Or Other Non-FDA Approved, Investigational Use

Jennifer Krejci, MD – Diagnosis, Approach and Medical Treatment for Female Hair Loss
Finasteride, Spironolactone, Laser Therapy, Platelet-Rich Plasma

Alejandra Susacasa, MD – Role of Mesotherapy in Female Hair Loss
Finasteride, Minoxidil

CME Information

Click for Continuing Medical Education Mission Statement

Learner Bill of Rights

ISHRS Privacy and Confidentiality Policy for Internet CME

Disclaimer

The webinar content has been made available by the ISHRS for educational purposes only. The content is not intended to represent the only, nor necessarily the best, method or procedure appropriate for the medical situations discussed, but rather is intended to present views, statements, and opinions that may be of interest to others. The views expressed herein are those of the individual authors and not necessarily those of the ISHRS. The ISHRS assumes no responsibility or liability in connection with your use or misuse of the webinar content or any materials or techniques described in the content, and it makes no warranty or representation as to the validity or sufficiency of any information provided. 

Questions: Learners may contact the ISHRS Headquarters with questions about this CME activity at phone +1-800-444-2737 or +1-630-262-5399, or fax +1-630-262-1520, or email: [email protected]